Here is the latest shareholding Pattern of DR HABEEBULLAH LIFE SCIENCES. For more details, see the DR HABEEBULLAH LIFE SCIENCES financial fact sheet and DR HABEEBULLAH LIFE SCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | 52.87 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 1.51 | 1.43 | 1.01 | 0.67 | 0.68 | 0.68 | 0.44 | 0.43 | |
Individuals | % | 40.15 | 40.27 | 40.68 | 40.99 | 40.99 | 40.96 | 41.19 | 41.14 | |
NRIs/OCBs | % | 5.47 | 5.43 | 5.44 | 5.46 | 5.46 | 5.48 | 5.50 | 5.56 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | |
Total Non-Institution | % | 47.13 | 47.13 | 47.13 | 47.13 | 47.13 | 47.13 | 47.13 | 47.13 | |
Total Public | % | 47.00 | 47.00 | 47.00 | 47.00 | 47.00 | 47.00 | 47.00 | 47.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.11 | |
Subscriber Feature |
More Trading Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Indian share markets continued the momentum as the session progressed and ended the higher.